Bio-Solutions Corp (OTCQB: BISU), a fast growing dietary supplement manufacturer, announced today that the company has restructured its senior management and also secured new capital. William Gallagher, CEO and Director, retired. Mr. Gallagher has agreed to serve the company as an advisor to the board of directors assisting with the new promotion of the company's lead product Type 2 Defense.
Type 2 Defense™ is a powder blend of natural ingredients that has been developed to help support healthy blood glucose levels in health-conscious individuals and those diagnosed with Type II Diabetes.
Company Thomas E. Metzger, PhD remarked, "We appreciate the effort of Bill Gallagher to bring the Company to this point." I am extremely excited to work with Bill and Peggy Knight, Executive Vice President of Marketing, to Market the Type2Defense product and realize our business plan. Mr. Metzger also announced the election of James Hodge as Chairman of the Board of Directors. Mr. Hodge currently serves as Board Chairman and CEO of ReelTime Rentals, Inc., overseeing and developing that company's business plan and strategic initiatives. He brings to Bio-Solutions access to capital, strong connections, and public company acumen. James will also assist in development of channel distribution partnerships.
Lastly, the company entered into a financing agreement with private equity firm Capital Consulting, Inc to provide for working capital, marketing and purchasing new inventory.
About Bio-Solutions
Bio-Solutions Corp. markets new and very effective organic products; our lead product is Type2 Defense™. Type2Defense™ a Diabetic Supplement Drink. Type2Defense™ is a new dietary supplement that has been developed to help support healthy blood glucose levels in health-conscious individuals and those diagnosed with Type 2 Diabetes, when substituted over many popular sugar and/or carbohydrate-laden alternatives. The Product's goal is to provide a safe and natural supplement that will assist in the stabilization of healthy glucose levels along with providing strong antioxidants and low carbohydrates. For more information about Type 2 Defense, visit our website http://www.type2defense.com/
"Safe Harbor" Statement under the Private Securities Litigation Reform Act of 1995: This release includes forward-looking statements intended to qualify for the safe harbor from liability established by the Private Securities Litigation Reform Act of 1995. All statements which address actual results could differ materially from those expressed or implied in forward-looking statements. These statements are made on the basis of management's views and assumptions. As a result, there can be no assurance that management's expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as management "believes", "expects", "anticipates", "foresees", "forecasts", "estimates" or other words or phrases of similar import. Similarly, statements in this release that describe the Company's business strategy, outlook, objectives, plans, intentions or goals also are forward-looking statements. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements. Management cautions that the ability to attract clients and generate business may be affected by a decline in the Company's financial ratings, the competitive environment, the Company's ability to raise sufficient capital to meet the collateral requirements associated with its current business and to fund the Company's continuing operations and changes in market conditions.
Contact:
Thomas Metzger, PhD
President
Bio-Solutions Corp.
Investor Relations Contact
Thomas Metzger
+1-210-218-4475
SOURCE: Bio-Solutions Corp
Associated Documentation:
Link to submission on http://www.eteligis.com
BISU_4-14-2014_LST_ETL.docx
To unsubscribe from any future mailings, please visit: http://www.eteligis.com/MassMailUnsubscribe.aspx
Copyright eTeligis Inc. 2014. All rights reserved.
0 comments:
Post a Comment